LFB Biomanufacturing
Christophe DOUAT is a skilled professional in health biology and therapeutic engineering with extensive experience in various scientific roles. Currently involved in the development of a GMP qPCR platform for DNA contamination at LFB Biomanufacturing, Christophe has also contributed to clinical trials assessing neuropsychological factors in suicidal recidivism at CHU de Montpellier. Previous roles include user experience studies with clinical diagnostic machines at Thermo Fisher Scientific, research on lung cancer mechanisms at BSRC Alexander Fleming, and participation in evolutionary anthropology studies with CNRS. Educational qualifications encompass multiple master's degrees in health biology from the University of Montpellier, along with early studies in biological engineering.
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.